Name: Pharmacovigilance: Beyond Signal Detection and Spontaneous Reporting
Start: 2025-06-16T15:45:00-0400
End: 2025-06-16T16:45:00-0400

Monday June 16, 2025 3:45pm - 4:45pm EDT

TBD

Component Type: Session
Level: Basic

An introduction to pharmacovigilance activities (with a focus of those beyond signal detection) along with considerations and approaches to mitigate, monitor, and evaluate potential signals in a real-world setting with use cases will be provided.

Learning Objectives

Explain the stages of Pharmacovigilance Beyond Signal Detection and Spontaneous Reporting; Describe Considerations for Planning for and Evaluating Post-Marketing Safety in a Real-World Setting.

Chair

Alicia Gilsenan, PhD, MS, RPh, FISPE

Speakers

Alicia Gilsenan

Vice President, Epidemiology, RTI Health Solutions, United States

Alicia Gilsenan, PhD, is Vice President, Epidemiology within RTI-HS and a licensed pharmacist. Dr. Gilsenan’s primary area of expertise is pharmacoepidemiology and therapeutic risk management and the structured benefit-risk assessment of medications. Since joining RTI in 1997, she... Read More →

Monday June 16, 2025 3:45pm - 4:45pm EDT
TBD Walter E. Washington Convention Center 801 Allen Y. Lew Place, NW Washington, DC 20001-3614 USA

01: ClinSafety-PV, Session

Level Basic
Level Basic
format csv
Tags Session

DIA 2025 Global Annual Meeting

Alicia Gilsenan

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!